Omnes Capital's investments

Sector 
SaaS / Cloud
Entry Date 
2018
Business 
Venture Capital

Vsora

Innovative DSP IP solutions

Founded in 2015, VSORA will introduce innovative DSP IP solutions to accelerate the design of complex integrated circuits, prevalent in the mobile, networking and consumer product markets. It has offices in Velizy-Villacoublay.

 

Latest news
Sector 
Pharma
Entry Date 
2012
Business 
Venture Capital

Enterome

Pioneer in personalised medicine harnessing the power of gut microbiome

Based in Paris, Enterome is an innovative theranostics company dedicated to discovering and developing biomarkers to diagnose and treat inflammatory conditions (Crohn’s disease, ulcerative colitis) linked to anomalies in intestinal composition using a unique platform that harnesses the power of the human microbiome. In addition to its inflammatory franchise, the Enterome platform can also be used for a vast range of applications such as monitoring and treating metabolic conditions (fatty liver, obesity, diabetes). 

Latest news
Sector 
Pharma
Entry Date 
2011
Business 
Venture Capital

Themis Bioscience

Next generation of prophylactic vaccines against emerging diseases

Themis Bioscience GmbH develops vaccines at the pre-clinical and early clinical stages.
The Vienna-headquartered company specialises in emerging tropical diseases. The first vaccine candidates currently under development target Chikungunya and Dengue fever. Themaxyn®, the innovative platform originally developed at the Pasteur Institute in Paris and protected by a number of patents, represents the vector for all the company’s current vaccine candidates.

 

Latest news
Sector 
Industry
Entry Date 
2017
Business 
Mid-Cap Buyout & Growth Capital

Aero Negoce International (ANI)

A fasteners distributor dedicated to the aerospace industry

Based in Béziers (Occitanie region in France) and created in 1993, the ANI group is a fasteners distributor dedicated to the aerospace industry. Its main customers are aircraft manufacturers (e.g. Airbus, Dassault) and their main suppliers (e.g. Zodiac, Safran).

Latest news
Sector 
Infrastructure
Entry Date 
2017
Business 
Green building

Foncière des Lunes

Investing in Darwin, a flagship renovation project
Omnes Capital and the Evolution incubator conclude partnership through La Foncière des Lunes to develop regional projects with high environmental standards Omnes is concluding a strategic partnership with Evolution by investing in La Foncière des Lunes. Through this partnership, Omnes aims to invest, alongside Evolution, in Darwin, a flagship renovation project on the right bank of the Garonne in Bordeaux. It will also promote several other projects (particularly renovation and restructuring of existing assets) with high environmental standards, dedicated to combined uses and the development of integrated ecosystems. These projects will be developed in the Bordeaux region as well as in other French cities.
Latest news
Sector 
Infrastructure
Entry Date 
2017
Business 
Green building

ETPOMNIA

High energy efficiency real estate projects in the Nantes region
Omnes Capital and the ETPO Group are creating ETPOMNIA, with the objective of financing the construction of 50,000 sq. m of high energy efficiency real estate projects in the Nantes region. With the partnership, the ETPO Group and Omnes Capital aim to develop 50,000 sq. m of high-energy efficiency commercial real estate projects in the next five years, primarily in the Nantes region.
Latest news
Sector 
Industry
Entry Date 
2017
Business 
Small-Cap Buyout & Growth Capital

Groupe RGF

Design and production of plastic and/or metal technical small parts

Based in Pratz (39), the Group specialises in the design and production of plastic and/or metal technical small parts in niche markets. It covers the entire production chain, including design, creation of moulds, injection, undercutting, overmoulding and automated assembly.Groupe RGF has established itself as a leading operator with over 20 years’ experience.

Latest news
Sector 
Mobile
Entry Date 
2017
Business 
Venture Capital

BANKIN'

Established in 2011, Bankin' has revolutionised the management of bank accounts using a mobile app that simplifies and clarifies money management. It offers an intelligent look at bank accounts and expense items (automatic categorisation) as well as monthly budgets. It also allows steering your money using a forecast end of month balance and automatic alerts of risks of overdraft.

Latest news
Sector 
Consumer goods
Entry Date 
2016
Business 
Small-Cap Buyout & Growth Capital

Ducatillon

Le leader français de la vente à distance de matériel d’élevage.

Founded in 1997, Ducatillon is France’s market leader in distance selling of hobby farming and hunting equipment and outdoor leisure goods. The company, which offers over 22,000 items, has a unique multi-specialist positioning in France spanning hunting attire and accessories, livestock equipment, gardening products, kitchen goods, canine accessories and fishing equipment.

Ducatillon’s strong growth over the last five years is thanks to (i) its high quality customer service, spearheaded by specialist sales advisors, (ii) its exclusive products (own-label brands and exclusive distribution agreements), (iii) its three complementary distribution networks (15 catalogues, 7 e-commerce sites and a showroom based in Cysoing).

Ducatillon has over 500,000 customers, with the number increasing regularly each year. It generated sales of €22 million in 2016 with 80 employees.

Latest news
Sector 
Pharma
Entry Date 
2016
Business 
Venture Capital

Horama

One of the leaders in ophthalmic diseases gene therapy,

Created in March 2014, Horama is developing new gene therapies for the treatment of hereditary retinopathies pigmentosa, which are orphan ophthalmological diseases. The company gathers the expertise of internationally renowned scientific experts in the field of ophthalmologic gene therapies. Its ambition is to help slow down visual loss and even improve the visual function by injecting a specific viral vector based on adeno-associated viruses (AAV). Horama’s scientific founding team (Nantes and Montpellier, France) is the first one in France to have completed an ophthalmology gene therapy study in 2011.

Latest news

Pages

NewsRoom
Publication
Scope, the Omnes review, November 2018
Press release
25 November 2019
Omnes welcomes on board two new Analysts
Omnes welcomes on board two new Analysts
Press release
20 November 2019
TISSIUM Closes €39M Series B Funding Round
TISSIUM Closes €39M Series B Funding Round
Press release
28 October 2019
Solvionic completes a €4 million funding round from Omnes and IRDI Soridec
Solvionic completes a €4 million funding round from Omnes and IRDI Soridec
Publication
Omnes’ Environmental, Social and Governance (ESG) commitments
Press release
08 October 2019
Omnes invests in Biosyl as part of a sponsorless deal
Omnes invests in Biosyl as part of a sponsorless deal
Press release
01 October 2019
Glennmont purchases 211MW unsubsidised Finnish wind project from Ilmatar Energy
Glennmont purchases 211MW unsubsidised Finnish wind project from Ilmatar Energy

Pages